Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 5EF45 | IM / LL |
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 4D255 | IM / LA |
patient received a dose of FluLaval influenza vaccine on 08/22/2025. Patient received another dose of the FluLaval influenza vaccine on 11/04/2025. The parent had reported that the child had not yet received a dose of the seasonal influenza vaccine prior to administration. There were no immediate adverse events after administration of the vaccine. Parent was notified immediately at the time of the incident and advised to monitor for and report any adverse events/signs/symptoms.
Pulmonic Valve Murmur
Albuterol Sulfate 0.63mg/3mL via nebulizer as needed, Cetirizine 1.5mg once a day by mouth, OTC melatonin
No known allergies
n/a